MyAverix Finance
SHG · Healthcare
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392)
Biotechnology
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $50.49B, P/E ratio is 18.00, net margin is -18.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) — FAQ
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's market cap?
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a reported market cap of $50.49B (data as of 2026-03-29).
What is 603392's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) is 18.00 (data as of 2026-03-29).
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Wantai Biological Pharmacy Enterprise Co Ltd in?
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603392 listed on?
603392 is listed on SHG.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net margin?
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) reports a net margin of -18.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.